Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,131,369
-
Share change
-
+1,683,063
-
Total reported value
-
$9,283,570,334
-
Put/Call ratio
-
84%
-
Price per share
-
$178.10
-
Number of holders
-
297
-
Value change
-
+$313,712,020
-
Number of buys
-
160
-
Number of sells
-
120
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2017
As of 31 Dec 2017,
BLUEBIRD BIO INC - COM (BLUE) was held by
297 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,131,369 shares.
The largest 10 holders included
FMR LLC, Capital Research Global Investors, BAILLIE GIFFORD & CO, Vanguard Group Inc, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, STATE STREET CORP, and OppenheimerFunds, Inc..
This page lists
297
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.